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SUMMARY
Previous studies have indicated that SAG1, the major surface molecule of the protozoan parasite Toxoplasma gondii, is an
important attachment ligand for the host cell. However, the research data that supports this claim comes largely from
studies investigating tachyzoite binding, and not SAG1 binding per se. In this study we successfully developed an in vitro
attachment assay to directly evaluate the mechanism of SAG1-host cell binding. Competition experiments were then
performed using SAG1 that had been pre-treated with the neoglycoprotein BSA-glucosamide or with antibody. Soluble
BSA-glucosamide blocked SAG1 attachment to MDBK cells in a dose-dependent manner, implying that SAG1 binding
is mediated, in part, via attachment to host cell surface glucosamine. Interestingly, pre-incubation of SAG1 in polyclonal
sera from chronically infected mice failed to block binding. This challenges the assumption that anti-SAG1 antibodies
block parasite attachment through the masking of SAG1 host cell binding domains. Taken together, this evidence presents
new strategies for understanding SAG1-mediated attachment.
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INTRODUCTION
Toxoplasma gondii is a globally prevalent protozoan
parasite aﬀecting all warm-blooded animals (Miller,
Frenkel & Dubey, 1972; Jackson & Hutchinson,
1989). It causes the disease toxoplasmosis which,
although generally asymptomatic, can be life threat-
ening in immunocompromised patients, such as those
suﬀering from AIDS (Luft & Remington, 1992).
The stage of the parasite responsible for dissemi-
nation of acute infection, termed the tachyzoite, is
promiscuous in vitro, invading every mammalian cell
line. While evidence that molecules secreted from
the microneme organelles direct the process of host
cell attachment is accumulating (Garcia-Re´guet et al.
2000; Reiss et al. 2001; Brecht et al. 2001; Lourenco
et al. 2001), the role of parasite surface molecules in
this process remains equivocal.
The tachyzoite surface, which presumably rep-
resents the primary interface with the host cell sur-
face, bears a number of glycophosphatidylinositol
(GPI)-anchored surface proteins (Nagel & Boot-
hroyd, 1989; Striepen et al. 1997), themost abundant
of which is a 30 kDa protein named SAG1 (Kasper,
Crabb & Pfeﬀerkorn, 1983; Burg et al. 1988). Four
lines of approach indirectly indicate that SAG1 binds
host cell surfaces. In vitro antibody neutralization
invasion assays demonstrate that a subset of anti-
SAG1 MAbs block tachyzoite invasion, implying
that SAG1 might function as a speciﬁc parasite
attachment ligand (Grimwood & Smith, 1992,
1996; Mineo et al. 1993; Mineo & Kasper, 1994).
Competitive invasion assays have shown that the
neoglycoprotein (NG) BSA-glucosamide blocks
the ability of wild-type parasites to bind host cells,
whereas those expressing truncated SAG1 remain
unaﬀected (Mineo et al. 1993). In more studies,
solubilized SAG1 has been shown to attach directly
to host cell surfaces (Fourmaux et al. 1996; Channon
et al. 1999; Velge-Roussel et al. 2001). These studies
have not, however, investigated the speciﬁcity of this
binding. Finally, the solution of the structure of
SAG1 reveals the presence of a basic groove at the
interface, formed during SAG1 dimerization (He
et al. 2002). This domain faces away from the para-
site surface and is therefore perfectly positioned for
interaction with host cell surface ligands.
Although anti-SAG1 MAbs and BSA-glucos-
amide inhibit tachyzoite attachment in vitro, it is not
known whether their blocking eﬀects are explicitly
mediated through masking host cell binding do-
mains on SAG1. For instance, antibody neutraliz-
ation experiments were used to investigate the ability
of anti-SAG1 MAbs to prevent tachyzoite binding,
rather than SAG1 binding. To address this question
we here investigate the inﬂuence of antibodies and
sugar-conjugates directly on SAG1.
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MATERIALS AND METHODS
Cell lines
All reagents for mammalian tissue culture were
purchased from GibcoBRL. HS27 Human foreskin
ﬁbroblast cells (ATCC, USA) were grown in
Dulbecco’s Modiﬁed Eagle Medium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum (FBS)
and incubated at 37 xC and 10% CO2 in air. MDBK
cells (adult bovine kidney; Madin & Darby, 1958;
Porton Down, UK) were grown in Ham’s F-12
nutrient mixture containing L-glutamine sup-
plemented with 10% FBS and incubated at 37 xC
and 5% CO2 in air.
Antibodies
The production of MAb C1E3 has been previously
described by Grimwood & Smith (1992). Polyclonal
immune mouse serum (IMS) was taken by cardiac
puncture from mice infected with the cystic strain
ME49. Anti-mouse IgG-HRP conjugate was from
Sigma–Aldrich, UK. Polyclonal IMS and MAb
C1E3 were aﬃnity-puriﬁed using a 1 ml Hi Trap
Protein G column (Amersham) following manu-
facturer’s instructions.
Preparation of tachyzoite proteins
Tachyzoites of the T. gondii RH strain were main-
tained by twice-weekly intraperitoneal passage in
Tucks number 1mice. Exudates were washed 3 times
by centrifugation at 3000 g for 10 min followed with
resuspension in phosphate-buﬀered saline (PBS),
pH 7.2. Parasite pellets were ﬁnally resuspended in
4 ml of solubilization buﬀer (50 mM NaHCO3, pH
9.0 containing 0.1% (v/v) NP40), incubated at 4 xC
for 1 h then freeze-thawed 3 times. Material was
sonicated on ice 5 times for 20 sec, centrifuged at
10 000 g for 5 min at 4 xC and the supernatant con-
taining solubilized tachyzoite lysate was used for
SAG1 puriﬁcation and binding assays.
Puriﬁcation of SAG1
SAG1 was puriﬁed in a one-step anion-exchange
high performance liquid chromatography (HPLC)
procedure. Four mg of 0.22 mm ﬁltered tachyzoite
lysate prepared in solubilization buﬀer was loaded
onto an AP1 column (Waters; diameter=0.8 cm,
height=7.5 cm) packed with 3.5 ml of DEAE fast-
ﬂow Sepharose (Amersham) and pre-incubated with
the same buﬀer. Solubilization buﬀer (10 column
volumes) was ﬂushed through the column at a ﬂow
rate of 1 ml/min. Non-adherent protein, comprising
pure SAG1, was collectedmanually in 1 ml fractions.
Bound protein was eluted from the column using 2 M
NaCl in solubilization buﬀer and dialysed against
solubilization buﬀer at 4 xC overnight. Sodium
dodecyl sulphate polyacrylamide gel electrophoresis
(SDS–PAGE) and immuno-blotting with anti-
SAG1 mAb C1E3 were used to assess the protein
proﬁles of fractions. Fractions containing puriﬁed
SAG1 were pooled, ﬂash-frozen in liquid N2 and
stored in 100 ml aliquots atx20 xC.
SDS–PAGE and immuno-blotting
SDS–PAGE was performed according to the
method of Laemmli (1970) using 10% separating
gels. Protein samples were not reduced. Following
electrophoresis, samples were either silver-stained
(Heukeshoven & Dernick, 1988), or transferred to
PVDF membrane (Schleicher and Schuell, Dassel,
Germany) as described by Towbin, Staehelin &
Gordon (1978). Following blocking for 1 h with 2%
(w/v) non-fat dry milk powder in PBST buﬀer
(PBS, 0.1% (v/v) Tween 20, pH 7.4), membranes
were incubated for 1 h at 37 xC in MAb C1E3 or
polyclonal IMS diluted 1 : 500 in PBST containing
5% (w/v) non-fat dry milk. After copious washes in
PBST buﬀer, proteins were revealed using horse-
radish peroxidase (HRP)-conjugated anti-mouse
IgG (diluted to 1 : 1000) followed by 3,3-diamino-
benzidine tetrahydrochloride substrate (DABS)
staining (Sigma–Aldrich).
Cell binding assays
The in vitro protein attachment assay was based on
a procedure by Fourmaux et al. (1996). Cells were
grown on 6-well dishes (9.5 cm2 wells) until conﬂu-
ent. Medium was discarded and cells were blocked
by 3r10 min washes with 10 ml of medium con-
taining 2% (w/v) bovine serum albumin (BSA). After
blocking, 0.5 mg of soluble tachyzoite lysate pre-
pared in 5 ml of medium was incubated on the con-
ﬂuent monolayer for 30 min at 37 xC. Non-adherent
lysate was discarded and following 6 washes in 10 ml
of medium, cells were solubilized by the addition
of 1 ml of 1r SDS–PAGE sample loading buﬀer
(75 mM Tris–HCl, pH 6.8, 5% (w/v) SDS, 0.0025%
(w/v) bromophenol blue) then detached using a cell
scraper. Samples were immediately subjected to
analysis by SDS–PAGE and immuno-blotting.
RESULTS
Puriﬁcation of SAG1 by anion-exchange
chromatography
Anion-exchange chromatography separates mol-
ecules according to charge diﬀerences. Using the Ex-
PASy Molecular Biology Server (http://www.ncbi.
nlm.nih.gov), the theoretical pI of mature SAG1
was calculated to be 7.5. This moderately high pI
was exploited to purify SAG1 by anion-exchange
HPLC. Tachyzoite lysates were fractionated by
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anion-exchange HPLC in column buﬀer at pH 9.0.
Silver staining and Western analysis (with MAb
C1E3) did not detect SAG1 in the bound tachyzoite
fraction (Fig. 1). At this pH SAG1 was the only
parasite protein that eluted from the ion-exchange
resin. Thus anion-exchangeHPLCproved to be very
eﬀective in separating virtually all SAG1 from
tachyzoite lysates. Interestingly, puriﬁcation at pH
8.5 and 8.0 fractionated SAG1 from most, but not
all, parasite proteins. From this, the actual pI of
solubilized SAG1 was deduced as being above 9.0.
SAG1 from total cell lysate binds to MDBK cells
and HS27 cell surfaces
The ﬁrst step was to investigate the binding of pro-
teins from tachyzoite lysates to the host cell surface.
Immune mouse sera (IMS) identiﬁed major bands
of approximately 28 kDa and 75 kDa in MDBK
cell extracts, and 28 kDa and 48 kDa in HS27 cell
extracts, following incubation of monolayers with
tachyzoite lysate (Fig. 2A). Comparing these frac-
tions to the protein proﬁle of tachyzoite total cell
Fig. 1. Anion-exchange HPLC puriﬁcation of SAG1. Tachyzoite lysates were fractionated by anion exchange at pH 9.0,
8.5 and 8.0. Flow-through (F and Fs) and bound (B and Bs) fractions were separated on a 12% (w/v) polyacrylamide
gel. Lanes T and Ts are non-fractionated tachyzoite lysates. Lanes Ts, Fs and Bs were silver-stained, lanes T, F and B
were analysed by immuno-blotting using anti-SAG1 MAb C1E3 as primary antibody. Cross-reacting bands were
detected using anti-mouse IgG HRP conjugate followed by DABS staining. Values on the right side indicate molecular
sizes of marker proteins in kDa.
Fig. 2. Binding of tachyzoite molecules to host cell surfaces. Immuno-blot analysis of (A) tachyzoite proteins binding
to MDBK and HS27 cells in the in vitro protein attachment assay, and (B) crude tachyzoite cell lysate. Host cells were
incubated with (lanes 2 and 4) or without (lanes 1 and 3) soluble tachyzoite lysate (0.5 mg), then washed and host cell
proteins separated by SDS–PAGE on a 12% (w/v) polyacrylamide gel. For immuno-blotting, proteins were analysed
with IMS (A, lanes 1 and 2; and B) or MAb C1E3 (A, lanes 3 and 4) used as primary antibody. Cross-reacting bands
were detected using anti-mouse IgG HRP conjugate followed by DABS staining. Values on the right side indicate
molecular sizes of marker proteins in kDa.
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lysate (Fig. 2B) revealed that many abundant tachy-
zoite proteins did not adhere to the host cell surfaces,
indicating that the binding of the 28 kDa, 48 kDa
and 75 kDa proteins was speciﬁc. Probing withMAb
C1E3 conﬁrmed the 28 kDa molecule as SAG1. No
bands were present in control, unincubated cell
extracts.
To minimize the likelihood that tachyzoite pro-
teins were present in the host cell fractions due to
internalization or receptor recycling, the in vitro
protein attachment assay was repeated at 4 xC to re-
tard host cell endocytotic machinery. Comparing the
results of attachment at 4 xCwith attachment at 37 xC
revealed no diﬀerences (data not shown), suggesting
that the tachyzoite proteins in host cell fractions
arose as a consequence of binding to the host cell
surfaces.
Eﬀect of neoglycoprotein BSA-glucosamide
on attachment of SAG1 to MDBK cells
We wanted to investigate the putative binding of
SAG1 to host cell-surface glucosamine. Competition
experiments were performed using SAG1 that had
been pre-treatedwith serial dilutions of the neoglyco-
protein BSA-glucosamide. Soluble BSA-glucos-
amide blocked SAG1 attachment to MDBK cells in
a dose-dependent manner; virtually all SAG1 bind-
ing was prevented with 100 mM BSA-glucosamide
(Fig. 3). The attachment blockade was shown to be
speciﬁc for glucosamide since control incubations
with BSA had no eﬀect on SAG1 binding (Fig. 3,
lane 8). Pre-incubation of host cells with BSA-
glucosamide or BSA had no eﬀect on their integrity
or morphology (data not shown). Taken together
these results illustrate that BSA-glucosamide com-
petes with host cell surfaces for SAG1 binding.
Eﬀect of neoglycoprotein antibody on attachment
of SAG1 to MDBK cells
SAG1 was pre-incubated with MAb C1E3 or poly-
clonal IMS to determine whether these agents
perturb the binding of SAG1 to host cell surface.
Preliminary incubation of SAG1 with a 4-fold molar
excess of MAb C1E3 did not inhibit attachment
of SAG1 to MDBK cell surfaces, and so it appears
that the MAb C1E3 epitope does not overlap with
the SAG1 domain for host cell binding (Fig. 4).
SAG1 could also bind host cell surfaces following
pre-incubation with a 4-fold molar excess of IMS.
These results demonstrate that immunodominant
B cell epitopes on SAG1 do not directly bind to the
surfaces of host cells. Interestingly, Western analysis
with MAb C1E3 detected minor bands of approxi-
mately 55 kDa, 120 kDa and 180 kDa in MDBK
cell extracts that had been incubated with the
SAG1-antibody mixtures (Fig. 4, lanes 2). These
molecules were resistant to reduction in 25 mM
Fig. 3. Inhibition of SAG1 attachment to MDBK cells
using BSA-glucosamide. SAG1 was pre-incubated with
the NG BSA-glucosamide prior to the in vitro protein
attachment assay. Incubated cells were fractionated by
SDS–PAGE on a 12% (w/v) polyacrylamide gel and
proteins detected by silver staining. Lane 1 contained
non-incubated MDBK cells, lane 2 is SAG1 and lane 3
contained MDBK cells incubated with 0.1 mg of SAG1.
Lanes 4–7 contained MDBK cells incubated in SAG1
that had been pre-treated with serial dilutions of
BSA-glucosamide (0.1 mM, 1 mM, 10 mM and 100 mM,
respectively). Lane 8 is SAG1 pre-treated with BSA alone.
Values on the right side indicate molecular sizes of marker
proteins in kDa.
Fig. 4. The role of SAG1 epitopes in SAG1 binding. The
binding of SAG1 epitopes to host cells was assessed by
pre-incubating SAG1 with either MAb C1E3 or IMS.
Incubated cells were fractionated by SDS–PAGE on a
12% (w/v) polyacrylamide gel and proteins were analysed
by Western blotting using anti-SAG1 MAb C1E3 as
primary antibody. Cross-reacting bands were detected
using anti-mouse IgG HRP conjugate followed by DABS
staining. Lane 1 contained MDBK cells incubated with
0.5 mg puriﬁed antibody. Lane 2 contained MDBK cells
incubated with 0.1 mg SAG1 that had been pre-treated
with 0.5 mg puriﬁed antibody. Values on the right side
indicate molecular sizes of marker proteins in kDa. Arrows
indicate the presence of higher molecular weight
complexes of SAG1 detected by MAb C1E3.
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DTT, and were therefore not oligomers of IgG
heavy chain (data not shown).
DISCUSSION
We have shown that SAG1 speciﬁcally binds the
surface of bovine kidney cells and human foreskin
ﬁbroblasts, thus adding to the collection of host cells
to which SAG1 attaches, i.e. Vero cells (Fourmaux
et al. 1996), monocytes (Channon et al. 1999) and
epithelial cells (Velge-Roussel et al. 2001).
The ﬁnding that attachment of SAG1 to bovine
kidney cells could be blocked by pre-incubation of
SAG1 in BSA-glucosamide is in agreement with a
previous study which found that the ability of BSA-
glucosamide to block invasion was markedly reduced
when SAG1-deﬁcient mutants were used in place of
wild-type parasites (Mineo et al. 1993). From this
result it would be tempting to suggest that SAG1
binding to host cells is mediated through interaction
with host cell-surface glucosamine. Even so, direct
binding of SAG1 to glucosamide has not been con-
ﬁrmed, and further work is required to assess the spe-
ciﬁcity of interaction with other sugar-conjugates.
Interestingly, it has been established that attach-
ment ofT. gondii to host cells is mediated, in part, by
the binding of parasite lectins to complex sugars
such as glycosaminoglycans, e.g. heparin (Ortega-
Barria & Boothroyd, 1999; Carruthers et al. 2000;
Jacquet et al. 2001). Recently, recombinant SAG3
(rSAG3) was shown to recognize sulphated proteo-
glycans on the surface of CHO-K1 (Jacquet et al.
2001). Modelling the SAG3 structure reveals that
the outside surface of the SAG3 groove is negatively
charged, which may apparently function to direct
speciﬁc binding of negatively charged heparin, a sul-
phated glycosaminoglycan, to the positively charged
groove (He et al. 2002). It is tempting to speculate
that the absence of this feature in rSAG1 allows
the protein to ubiquitously attach to sulphated and
non-sulphated cell surface gylcans. Even so, whilst
Jacquet et al. (2001) demonstrated that rSAG3 binds
with high aﬃnity to heparin, these authors found
no evidence for the binding of rSAG1 to heparin.
However, host cell binding regions may not be cor-
rectly folded on rSAG1, and so the binding of
native SAG1 to sulphated proteoglycans cannot be
ruled out.
It is unlikely that all host cells will exhibit the
same surface receptors or that a single parasite sur-
face protein couldmediate invasion of every cell type.
Thus, it is likely that there is redundancy in these
ligands. For example, in this paper we have shown
that SAG1 can bind human foreskin ﬁbroblasts,
although Dzierszinski et al. (2000) have shown that
SAG3 also binds this cell type. Disruption of the
SAG3 gene reduces, but does not abolish invasion,
and thus SAG1 could be responsible for mediating
parasite attachment to this cell type. Even so, the
presence of the diverse family of SAG1-related
sequence (SRS) proteins may circumvent the need
for both SAG1 and SAG3, making the parasite
even more versatile. Interestingly, eﬀorts to create
a SAG1/SAG3 knockout have so far been unsuc-
cessful.
One intriguing ﬁnding was the discovery that
SAG1 forms high molecular weight complexes by
self-association. These data corroborate the ﬁnding
that rSAG1 forms dimers in solution (He et al.
2002), though the observations presented here also
imply that SAG1 can also form heteromers and
hexamers. The behaviour of SAG1 could be charac-
terized in two ways. First, higher complexes were
not present subsequent to puriﬁcation, only appear-
ing once SAG1 had been stored atx20 xC. Second,
the absence of a band of approximately 80–90 kDa
indicates that SAG1 does not form trimers, thus
each complex is a multimeric association of SAG1
dimers.
In vitro invasion assays using anti-SAG1 MAb
C1E3 have previously indicated that SAG1 has a role
in host cell attachment (Grimwood & Smith, 1992,
1996). In these experiments, MAb C1E3 was used to
perturb parasite invasion, and since only a subset of
anti-SAG1 MAbs conveyed this eﬀect it has been
postulated that the blocking ability of MAb C1E3
was due to the masking of a speciﬁc epitope of
SAG1. With the sole purpose of understanding the
mechanism of anti-SAG1 MAb neutralization, the
stoichiometry of these antibody–antigen interactions
was addressed. Unexpectedly, the results presented
here indicate that MAb C1E3 does not in fact block
SAG1 binding to host cell surfaces. To comprehend
this peculiar ﬁnding, the interaction between MAb
C1E3 and SAG1 requires further investigation.
Since MAb C1E3 binding appears to be implicitly
linked to the process of host cell attachment, the
identiﬁcation of the epitope for this MAb on SAG1
could provide a valuable insight into the role of
SAG1 epitopes in host cell attachment.
We thank Debra Evans and Sinead Moore for their expert
technical assistance.
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